131 related articles for article (PubMed ID: 7520318)
1. Effects of alternate-day or daily prednisone treatment on GH and cortisol levels in growth-retarded children after renal transplantation.
Hokken-Koelega AC; de Muinck Keizer-Schrama SM; Drop SL
J Pediatr Endocrinol; 1994; 7(2):119-25. PubMed ID: 7520318
[TBL] [Abstract][Full Text] [Related]
2. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation.
Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Blum WF; Drop SL
J Clin Endocrinol Metab; 1993 Oct; 77(4):932-8. PubMed ID: 7691864
[TBL] [Abstract][Full Text] [Related]
3. Twenty-four-hour plasma growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation.
Hokken-Koelega AC; Hackeng WH; Stijnen T; Wit JM; de Muinck Keizer-Schrama SM; Drop SL
J Clin Endocrinol Metab; 1990 Sep; 71(3):688-95. PubMed ID: 2394775
[TBL] [Abstract][Full Text] [Related]
4. Correlation between cortisol and insulin-like growth factor-binding proteins (IGFBPs) under physiological conditions in children.
Martinelli CE; Yateman ME; Cotterill AM; Moreira AC; Camacho-Hübner C
Clin Endocrinol (Oxf); 1999 Jun; 50(6):767-74. PubMed ID: 10468949
[TBL] [Abstract][Full Text] [Related]
5. Failure to increase insulin-like growth factor-I synthesis is involved in the mechanisms of growth retardation of children with inherited liver disorders.
Maghnie M; Barreca A; Ventura M; Tinelli C; Ponzani P; De Giacomo C; Maggiore G; Severi F
Clin Endocrinol (Oxf); 1998 Jun; 48(6):747-55. PubMed ID: 9713564
[TBL] [Abstract][Full Text] [Related]
6. Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation. The Dutch Working Group on Growth Hormone.
de Waal WJ; Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Drop SL
Clin Endocrinol (Oxf); 1994 Nov; 41(5):621-30. PubMed ID: 7828352
[TBL] [Abstract][Full Text] [Related]
7. The effect of recombinant human insulin-like growth factor-I treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome).
Cotterill AM; Camacho-Hübner C; Holly JM; Savage MO
Clin Endocrinol (Oxf); 1993 Jul; 39(1):119-22. PubMed ID: 7688671
[TBL] [Abstract][Full Text] [Related]
8. Effect of growth hormone administration frequency on 24-hour growth hormone profiles and levels of other growth related parameters in girls with Turner's syndrome. Dutch Working Group on Growth Hormone.
van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Mouton JW; Blum WF; Mercado M; Baumann G; Drop SL
Clin Endocrinol (Oxf); 1993 Jul; 39(1):77-84. PubMed ID: 7688672
[TBL] [Abstract][Full Text] [Related]
9. A placebo-controlled, double-blind trial of growth hormone treatment in prepubertal children after renal transplant.
Hokken-Koelega AC; Stijnen T; de Jong RC; Donckerwolcke RA; Groothoff JW; Wolff ED; Blum WF; de Muinck Keizer-Schrama SM; Drop SL
Kidney Int Suppl; 1996 Jan; 53():S128-34. PubMed ID: 8771007
[TBL] [Abstract][Full Text] [Related]
10. Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus.
Bereket A; Lang CH; Blethen SL; Gelato MC; Fan J; Frost RA; Wilson TA
J Clin Endocrinol Metab; 1995 Apr; 80(4):1312-7. PubMed ID: 7536205
[TBL] [Abstract][Full Text] [Related]
11. Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature.
Cotterill AM; Camacho-Hübner C; Duquesnoy P; Savage MO
Clin Endocrinol (Oxf); 1998 Jun; 48(6):719-24. PubMed ID: 9713560
[TBL] [Abstract][Full Text] [Related]
12. Metabolic effects of growth hormone administered subcutaneously once or twice daily to growth hormone deficient adults.
Laursen T; Jørgensen JO; Christiansen JS
Clin Endocrinol (Oxf); 1994 Sep; 41(3):337-43. PubMed ID: 7525120
[TBL] [Abstract][Full Text] [Related]
13. The evolution of changes in immunoreactive serum insulin-like growth factors (IGFs), IGF-binding proteins, circulating growth hormone (GH) and GH-binding protein as a result of short-term dexamethasone treatment.
Miell JP; Buchanan CR; Norman MR; Maheshwari HG; Blum WF
J Endocrinol; 1994 Sep; 142(3):547-54. PubMed ID: 7525826
[TBL] [Abstract][Full Text] [Related]
14. Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency.
Hokken-Koelega AC; Stijnen T; De Jong MC; Donckerwolcke RA; De Muinck Keizer-Schrama SM; Blum WF; Drop SL
J Clin Endocrinol Metab; 1994 Oct; 79(4):1185-90. PubMed ID: 7525628
[TBL] [Abstract][Full Text] [Related]
15. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
Smith WJ; Nam TJ; Underwood LE; Busby WH; Celnicker A; Clemmons DR
J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone treatment in growth-retarded adolescents after renal transplant.
Hokken-Koelega AC; Stijnen T; de Ridder MA; de Muinck Keizer-Schrama SM; Wolff ED; de Jong MC; Donckerwolcke RA; Groothoff JW; Blum WF; Drop SL
Lancet; 1994 May; 343(8909):1313-7. PubMed ID: 7910322
[TBL] [Abstract][Full Text] [Related]
17. Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure.
Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Wit JM; Wolff ED; de Jong MC; Donckerwolcke RA; Abbad NC; Bot A; Blum WF
Lancet; 1991 Sep; 338(8767):585-90. PubMed ID: 1715501
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factors (IGF) I and II and IGF binding proteins 1, 2 and 3 during low-dose growth hormone (GH) infusion and sequential euglycemic and hypoglycemic glucose clamps: studies in GH-deficient patients.
Jørgensen JO; Blum WF; Horn N; Møller N; Møller J; Ranke MB; Christiansen JS
Acta Endocrinol (Copenh); 1993 Jun; 128(6):513-20. PubMed ID: 7687807
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of insulin-like growth factor binding protein-3 in the evaluation and treatment of short children with suspected growth hormone deficiency.
Hasegawa Y; Hasegawa T; Aso T; Kotoh S; Nose O; Ohyama Y; Araki K; Tanaka T; Saisyo S; Yokoya S
Eur J Endocrinol; 1994 Jul; 131(1):27-32. PubMed ID: 7518726
[TBL] [Abstract][Full Text] [Related]
20. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
